Agilent Technologies Separates Bioanalytical Business into Two Groups
Agilent Technologies (Santa Clara, California) announced the separation of its Life Science and Chemical Analysis Group into two businesses, Chemical Analysis and Life Sciences.
Agilent Technologies (Santa Clara, California) announced the separation of its Life Science and Chemical Analysis Group into two businesses, Chemical Analysis and Life Sciences. Mike McMullen has been promoted to senior vice president of Agilent and to president of the Chemical Analysis Group, and Nick Roelofs has been promoted to senior vice president of Agilent and to president of the Life Sciences Group. According to Bill Sullivan, Agilent president and CEO, “The decision to create two separate businesses within bioanalytical measurement reflects the need to serve distinct sets of customers, along with Agilent’s commitment to building a stronger presence in bioanalytical markets.” Effective November 1, 2009, Agilent will comprise three separate business groups: Electronic Measurement, Chemical Analysis, and Life Sciences.
The Reality Behind Column Insertion Distance
September 10th 2024Column insertion distance is critical to good chromatography. What happens if the column is installed too low in the injection port? Is insertion distance more important when performing split injection or splitless injection? Does the position of the column in the injection port impact reproducibility?
Modern HPLC Strategies: Improving Retention and Peak Shape for Basic Analytes
August 16th 2024In high-performance liquid chromatography (HPLC), it is common for bases and unreacted ionized silanols on silica-based columns to cause irreproducible retention, broad peaks, and peak tailing when working with basic analytes. David S. Bell, Lead Consultant at ASKkPrime LLC offers innovative HPLC strategies that can help mitigate such issues.
